SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 10 2021
Historique:
received: 16 12 2020
accepted: 22 09 2021
entrez: 9 10 2021
pubmed: 10 10 2021
medline: 25 2 2023
Statut: epublish

Résumé

There are currently no cures for coronavirus infections, making the prevention of infections the only course open at the present time. The COVID-19 pandemic has been difficult to prevent, as the infection is spread by respiratory droplets and thus effective, scalable and safe preventive interventions are urgently needed. We hypothesise that preventing viral entry into mammalian nasal epithelial cells may be one way to limit the spread of COVID-19. Here we show that N-palmitoyl-N-monomethyl-N,N-dimethyl-N,N,N-trimethyl-6-O-glycolchitosan (GCPQ), a positively charged polymer that has been through an extensive Good Laboratory Practice toxicology screen, is able to reduce the infectivity of SARS-COV-2 in A549

Identifiants

pubmed: 34625610
doi: 10.1038/s41598-021-99404-8
pii: 10.1038/s41598-021-99404-8
pmc: PMC8501059
doi:

Substances chimiques

Antiviral Agents 0
Nasal Sprays 0
Surface-Active Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20012

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Cell Res. 2020 Apr;30(4):343-355
pubmed: 32231345
J Am Chem Soc. 2020 Mar 18;142(11):5252-5265
pubmed: 32105452
PLoS One. 2010 Dec 14;5(12):e14320
pubmed: 21179403
Food Chem. 2012 May 1;132(1):493-8
pubmed: 26434321
PLoS One. 2016 Jun 01;11(6):e0156552
pubmed: 27249425
Nat Neurosci. 2021 Feb;24(2):168-175
pubmed: 33257876
Sci Signal. 2020 Nov 24;13(659):
pubmed: 33234691
BMJ. 2020 Oct 22;371:m4072
pubmed: 33093025
Mol Pharm. 2015 Feb 2;12(2):420-31
pubmed: 25558881
Mol Pharm. 2012 Jun 4;9(6):1665-80
pubmed: 22574705
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:735-742
pubmed: 28482585
J Pharm Sci. 2014 Aug;103(8):2296-306
pubmed: 24916193
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Appl Environ Microbiol. 2015 Jan;81(2):464-9
pubmed: 25362069
Lancet Neurol. 2021 Apr;20(4):247
pubmed: 33743226
Sci Rep. 2016 Jun 29;6:28729
pubmed: 27353250
Drug Chem Toxicol. 2021 Jul;44(4):335-340
pubmed: 31179762
J Virol. 2021 Jan 28;95(4):
pubmed: 33219167
Antiviral Res. 2013 Feb;97(2):112-21
pubmed: 23201315
Prikl Biokhim Mikrobiol. 2011 Jan-Feb;47(1):113-8
pubmed: 21442928
J Food Prot. 2009 Dec;72(12):2623-8
pubmed: 20003751
Nat Struct Mol Biol. 2020 Sep;27(9):846-854
pubmed: 32661423
J Glob Health. 2019 Dec;9(2):020421
pubmed: 31673337
J Virol. 2020 Jul 16;94(15):
pubmed: 32434888
Prikl Biokhim Mikrobiol. 2002 Jan-Feb;38(1):5-13
pubmed: 11852567
Mol Pharm. 2012 Jan 1;9(1):14-28
pubmed: 22047066
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
Plant Physiol Biochem. 2006 Nov-Dec;44(11-12):893-900
pubmed: 17097297
N Engl J Med. 2020 Sep 17;383(12):1191
pubmed: 32813941
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086
pubmed: 29348203
EBioMedicine. 2021 Mar;65:103255
pubmed: 33676899
Multidiscip Respir Med. 2014 Nov 12;9(1):57
pubmed: 25411637
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
J Control Release. 2018 Jan 28;270:135-144
pubmed: 29191784

Auteurs

Krzysztof Pyrć (K)

Laboratory of Virology and ABSL3 Animal Facility at the Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.

Aleksandra Milewska (A)

Laboratory of Virology and ABSL3 Animal Facility at the Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.

Emilia Barreto Duran (EB)

Laboratory of Virology and ABSL3 Animal Facility at the Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.

Paweł Botwina (P)

Laboratory of Virology and ABSL3 Animal Facility at the Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.

Agnieszka Dabrowska (A)

Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Krakow, Poland.

Malwina Jedrysik (M)

Laboratory of Virology and ABSL3 Animal Facility at the Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.

Malgorzata Benedyk (M)

Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Krakow, Poland.

Rui Lopes (R)

Nanomerics Ltd., 6th Floor, 2 London Wall Place, London, EC2Y 5AU, UK.
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.

Alejandro Arenas-Pinto (A)

Centre for Clinical Research in Infection and Sexual Health, UCL Institute for Global Health, Mortimer Market Centre, off Capper Street, London, WC1E 6JB, UK.
MRC-Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, 90 High Holborn, London, WC1V 6LJ, UK.

Moutaz Badr (M)

Nanomerics Ltd., 6th Floor, 2 London Wall Place, London, EC2Y 5AU, UK.
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.

Ryan Mellor (R)

Nanomerics Ltd., 6th Floor, 2 London Wall Place, London, EC2Y 5AU, UK.
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.

Tammy L Kalber (TL)

Centre for Advanced Biomedical Imaging (CABI), Division of Medicine, University College London, London, WC1E 6DD, UK.

Delmiro Fernandez-Reyes (D)

Computer Science Department, University College London, Gower Street, London, WC1E 6BT, UK.

Andreas G Schätzlein (AG)

Nanomerics Ltd., 6th Floor, 2 London Wall Place, London, EC2Y 5AU, UK.
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.

Ijeoma F Uchegbu (IF)

Nanomerics Ltd., 6th Floor, 2 London Wall Place, London, EC2Y 5AU, UK. ijeoma.uchegbu@ucl.ac.uk.
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK. ijeoma.uchegbu@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH